TETAVAX

This brand name is authorized in Estonia, Hong Kong, Croatia, Malta, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug TETAVAX contains one active pharmaceutical ingredient (API):

1 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07AM01 Tetanus toxoid J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AM Tetanus vaccines
Discover more medicines within J07AM01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1114300, 1114311
Country: HK Department of Health Drug Office Identifier(s): 57877
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-943015948
Country: MT Medicines Authority Identifier(s): MA573/00402, PI770/08801A
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W58634001, W58634002, W58634003, W58634004
Country: SG Health Sciences Authority Identifier(s): 13513P, 13657P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699625960107
Country: ZA Health Products Regulatory Authority Identifier(s): 29/30.1/0637

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.